|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
����άϸ����������2 |
|
������ |
|
���� |
| ��������������� | |
|
���� |
|
�ｨ�� |
| PubMed | |
|
Article by |
|
Article by |
�Լ��Գ���άϸ���������Ӽ�������Ϊ�е�ĺ���������
����, �ｨ��
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о���, �Ͼ� 210042
���Գ���άϸ���������ӵĴ���ֳ�ʹ�Ѫ���γɵĹ����ں������ķ�������չ��ת��������Ҫ����.���������Գ���άϸ���������Ӽ�������Ϊ�е�ĺ��������Ƶ��о�������,�������������Ƶ������ԺͰ������ѳ�Ϊ��ǰ��������ѧ�е��о��ȵ�.
[2] Alanko T,Rosenberg M,Saksela O.FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes.J Invest Dermatol,1999,113(1):111-116.
[3] Vlodavsky I,Elkin M,Pappo O,et al.Mammalian heparanase as mediator of tumor metastasis and angiogenesis.Isr Med Assoc J,2000,2(Suppl):37-45.
[4] Nesbit M,Nesbit HK,Bennett J,et al.Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes.Oncogene,1999,18(47):6469-6476.
[5] Coleman AB,Lugo TG.Normal human melanocytes that express a bFGF transgene still require exogenous bFGF for growth in vitro.J Invest Dermatol,1998,110(5):793-799.
[6] Vacca A,Ria R,Ribatti D,et al.Angiogenesis and tumor progres sion in melanoma.Recenti Prog Med,2000,91(11):581-587.
[7] Graeven U,Rodeck U,Karpinski S,et al.Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.Cancer Res,2001,61(19):7282-7290.
[8] Berking C,Takemoto R,Satyamoorthy K,et al.Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin.Am J Pathol,2001,158(3):943-953.
[9] Xerri L,Battyani Z,Grob JJ,et al.Expression of FGF1 and FGFR1 in human melanoma tissues.Melanoma Res,1996,6(3):223-230.
[10] Ahmed NU,Ueda M,Ito A,et al.Expression of fibroblast growth factor receptors in naevus-eell naevus and malignant melanoma.Melanoma Res,1997,7(4):299-305.
[11] Geissinger E,Weisser C,Fischer P,et al.Autocrine stimulation by osteopontin contributes to antiapoptotie signalling of melanocytes in dermal collagen.Cancer Res,2002,62(16):4820-4828.
[12] Westphal JR,Vant Hullenaar R,Peek R,et al.Angiogenic balance in human melanoma:expression of VEGF,bFGF,IL-8,PDGF and angiostatin in relation to vascular density of xenografts in vivo.Int J Cancer,2000,86(6):768-776.
[13] Auslender S,Barzilai A,Goldberg I,et al.Lentigo maligna and superficial spreading melanoma are different in their in situ phase:an immunohistochemical study.Hum Pathol,2002,33(10):1001-1005.
[14] Straume O,Akslen LA.Importance of vascular phenotype by basic fibroblast growth factor,and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrinA1/EphA2 on melanoma progression.Am J Pathol,2002,160(3):1009-1019.
[15] Wang Y,Becker D.Antisense targeting of basic fibroblast growth fac tor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth.Nat Med,1997,3(8):887-893.
[16] Valesky M,Spang AJ,Fisher GW,et al.Noninvasive dynamic fluorescence imaging of human melanomas reveals that targeted inhibition of bFGF or FGFR-1 in melanoma cells blocks tumor growth by apotosis.Mol Med,2002,8(2):103-112.
[17] Aviezer D,Iozzo RV,Noonan DM,et al.Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense eDNA.Mol Cell Biol,1997,17(4):1938-1946.
[18] Sharma B,Handler M,Eichstetter I,et al.Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo.J Clin Invest,1998,102(8):1599-1608.
[19] Plum SM,Holaday JW,Ruiz A,et al.Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development.Vaccine,2000,19(9-10):1294-1303.
[20] Torcia M,Lucibello M,De Chiara G,et al.Interferon-alpha-induced inhibition of B16 melanoma cell proliferation:interference with the bFGF autocrine growth circuit.Biochem Biophys Res Commun,1999,262(3):838-844.
[21] Futami J,Seno M,Ueda M,et al.Inhibition of cell growth by a fused protein of human ribonuclease 1 and human basic fibroblast growth factor.Protein Eng,1999,12(11):1013-1019.
[22] Davol PA,Bizuneh A,Frackelton AR Jr.Wortmannin,a phosphoinositide 3-kinase inhibitor,selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.Anticancer Res,1999,19(3A):1705-1713.
[23] Davol PA,Garza S,Frackelton AR Jr.Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model.Cancer,1999,86(9):1733-1741.
[24] Satyamoorthy K,Soballe PW,Soans F,et al.Adenovirus infection enhances killing of melanoma cells by a mitotoxin.Cancer Res,1997,57(10):1873-1876.
[25] Kumar CC,Malkowski M,Yin Z,et al.Inhibition of angiogenesis and tumor growth by SCH221153,a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.Cancer Res,2001,61(5):2232-2238.